002550.SZ · 千红制药
China A-shares · RS rating 32 · As of 2026-10-14
| Price | 6.26 CNY |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 57 / 43 / 19 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 23 / 13 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +11.8% |
| Distance from 52-week high | +32.8% |
| Market cap (USD) | $1.2B |